Exemplos de uso de Methysergide em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Methysergide is a 5-HT2A antagonist and nonselective 5-HT1 receptor blocker.
Other effective options are glucocorticoids, lithium,topiramate and methysergide.
Methysergide was the first drug used to preventively treat migraine.
The incidence of pleural andcardiac RF is 1:5000 patients treated with methysergide.
Methysergide 1 mg/day was started with satisfactory migraine control.
Approximately 20% to 45% of patients experience methysergide side-effects and approximately 10% of them discontinue its use.
Methysergide and methylergometrine half-life is 60 and 220 minutes, respectively.
After 6 months,5-HTP was found to be as effective as methysergide in reducing the severity and duration of migraines.
Methysergide(not sold in Spain) is a powerful Serotoninergic antagonist, effective in prophylaxis.
There has been no direct causal relationship between methysergide and RF in these patients, but no other cause for such change was found.
Methysergide is used exclusively to treat episodic and chronic migraine and for episodic and chronic cluster headaches.
They are also not indicated for concomitant administration with ergotamine and its derivatives(including methysergide), with MAOI and between them.
Pizotifen and methysergide are reserved for patients who do not respond to other types of prophylaxis.
Analgesics caffeine, calcium channel blockers, clonidine,ergotamine, methysergide, opiates, and salicylates, among others might trigger rebound hyperalgesia.
Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
Fifteen minutes after the administration of saline,naloxone, or methysergide, according to the group, the animals received the first application of white light or LLL.
Methysergide, a butanolamine of 1-methyl-d-lisergic acid, is a non-specific serotonin receptor antagonist used in several animal studies on serotonergic pain modulation.
Case reports suggest that non-specific serotonin antagonists(eg chlorpromazine, methysergide, cyproheptadine or propranolol) may be beneficial in severe cases.
Seven days after methysergide dose decrease to 1 mg/day, clinical changes were totally resolved.
New and very efficient prophylactics were gradually being introduced in the therapeutic armamentarium: amitriptyline, calcium channel blockers,antiserotoninics pizotifen, methysergide among others.
After 24 months of continuous methysergide use, painless asymmetric lower limbs edema, more severe to the left, was observed.
Other causes include: actinomycosis, syphilis, infection with Aspergillus flavus or Wuchereria bancrofti, as well as coccidioidomycosis, zygomycosis, nocardiosis, sarcoidosis, silicosis,trauma and use of methysergide.
Several doses of subarachnoid phentolamine and methysergide are used in rats, and in the present study we used doses already described and that are commonly used by other authors.
The objective of the present study was to evaluate the effects of the subarachnoid administration of the adrenergic antagonist, phentolamine,serotonergic antagonist, methysergide, and the association of both antagonists on modulation of pain induced by the modified phormaline test.
Methysergide is one of the most effective medications for the prevention of migraine, but is not intended for the treatment of an acute attack, it is to be taken daily as a preventative medication.
This study aimed at reporting two cases of primary chronic headache 1 patient with migraine and one patient with cluster headache, refractory to first line drugs,who obtained an adequate control after using methysergide, which was withdrawn due to suspicion of retroperitoneal fibrosis RF.
Methysergide 1 mg at every 12 hours was started, with adequate control of cluster headache attacks and with patient reporting significant QL improvement after the introduction of the drug.
In this study, during phase II of the modified phormaline test, a significant difference was observed in nociceptive response when the phentolamine andphentolamine associated with methysergide groups were compared to the methysergide group, which might be explained by the antagonistic effect of phentolamine in?2 receptors, promoting a?1 effect.
Laser+ Methysergide Group- the LLL+ Methysergide group differed from the Control group in the generalized linear model analysis, but differences were not observed when it was compared to the Laser group.
This data suggests that the dose of phentolamine was high enough to inhibit almost completely the adrenergic descending system and that the dose of methysergide was not elevated enough to inhibit completely the serotonergic descending pathway; however, the association of both drugs seems to have been enough to inhibit the descending serotonergic and adrenergic inhibitory activities.